Skin aging involves collagen cross-linking and degradation, elastin loss, reduced hyaluronic acid production, impaired wound healing, and epigenetic changes in skin fibroblasts. UV exposure, oxidative stress, and GH/IGF-1 decline accelerate these changes. Peptide research offers the most mechanistically targeted approach to skin rejuvenation available.
1. GHK-Cu — Collagen / Elastin / Gene Rejuvenation
GHK-Cu is the gold standard skin rejuvenation peptide. It stimulates collagen I, III, and V synthesis, elastin production, glycosaminoglycan synthesis, and activates over 4,000 skin genes — restoring gene expression patterns toward a younger phenotype. It also promotes angiogenesis in the dermis and has antioxidant, anti-inflammatory properties in skin tissue.
Dosing Protocol: Topical: 0.5–2% GHK-Cu serum applied AM and PM. Systemic: 1–2 mg SubQ daily for full-body collagen support. Minimum 12 weeks for visible collagen remodeling.
2. Epithalon — Pineal / Antioxidant / Telomere Protection
Skin aging is partly driven by cellular senescence — cells that have stopped dividing and secrete pro-aging inflammatory factors. Epithalon reduces skin cellular senescence by activating telomerase, lengthening telomeres in skin fibroblasts. It also activates SOD and catalase in skin tissue, reducing the oxidative damage that drives photoaging.
Dosing Protocol: 5–10 mg SubQ daily for 10-day courses. 2–4x per year. Combined with topical GHK-Cu for comprehensive approach.
3. BPC-157 — Dermal Vascularity / Wound Repair
Aging skin has impaired dermal vascularity — reducing oxygen and nutrient delivery to fibroblasts. BPC-157 restores dermal angiogenesis, improving the metabolic support for collagen-producing fibroblasts. It also accelerates wound healing and reduces the scarring that replaces normal skin architecture after injuries.
Dosing Protocol: 250–500 mcg SubQ daily for systemic dermal effects. Cycle: 6–8 weeks.
4. IGF-1 LR3 — Fibroblast Proliferation
IGF-1 declines significantly with age, directly reducing skin fibroblast activity and collagen synthesis capacity. IGF-1 LR3 restores the anabolic growth factor signal driving fibroblast proliferation and extracellular matrix production — amplifying the effects of topical GHK-Cu by ensuring an adequate number of active fibroblasts.
Dosing Protocol: 20–40 mcg SubQ daily. Cycle: 4 weeks on, 4–6 weeks off.
GHK-Cu works directly on fibroblasts and skin gene expression — the most targeted skin rejuvenation intervention at the cellular level. Epithalon protects skin cells from senescence and oxidative aging. BPC-157 maintains the dermal vascularity that fibroblasts depend on. IGF-1 LR3 ensures a robust population of active fibroblasts to produce the collagen and matrix proteins that define youthful skin structure.
Research Use Only. All information on this page is for educational purposes only and is not medical advice. PepSherpa does not sell peptides. Consult a licensed healthcare provider before making any health decisions. Many of the studies cited are preclinical (animal/in-vitro).